Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Int J Med Microbiol. 2016 Aug 25;306(8):697–706. doi: 10.1016/j.ijmm.2016.08.004

Table 2.

Immunization with truncated LPS OMVs protected mice against oral challenge with S. Typhimurium strain S100.

Groups

Immunization administration
No. of surviving mice/total No. of micea
Intranasal route Intraperitoneal route
χ3761 (wild-type) 4/5 (80%) 5/5 (100%)
χ12253 (ΔwaaC12) 4/5 (80%) 5/5 (100%)
χ12252 (ΔwaaF15) 2/5 (40%) 3/5 (60%)
χ11308 (ΔwaaG42) 0/5 (0%) 2/5 (40%)
χ9945 (ΔrfaH49) 3/5 (60%) 5/5 (100%)
χ11309 (ΔwaaI43) 0/5 (0%) 2/5 (40%)
χ11310 (ΔwaaJ44) 3/5 (60%) 3/5 (60%)
χ11312 (ΔwaaL46) 1/5 (20%) 3/5 (60%)
χ11311 (ΔrfbP45) 4/5 (80%) 4/5 (80%)
χ9944 (Δwzy-48) 1/5 (20%) 3/5 (60%)
PBS group 0/5 (0%) 0/8 (0%)
a

All vaccine groups except groups of intranasal immunization of χ11309 (ΔwaaI43) and χ11308 (ΔwaaG42) were significantly different from the PBS-vaccinated group (P < 0.01). There was no significant difference in protection among the other groups.